Last reviewed · How we verify
Dexamethasone and aprepitant
Dexamethasone and aprepitant is a Small molecule drug developed by Yeditepe University Hospital. It is currently FDA-approved.
At a glance
| Generic name | Dexamethasone and aprepitant |
|---|---|
| Sponsor | Yeditepe University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile (PHASE2)
- 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC (PHASE2)
- Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer (PHASE3)
- Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients (PHASE3)
- To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy. (PHASE3)
- Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data (PHASE3)
- Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy (PHASE3)
- Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexamethasone and aprepitant CI brief — competitive landscape report
- Dexamethasone and aprepitant updates RSS · CI watch RSS
- Yeditepe University Hospital portfolio CI
Frequently asked questions about Dexamethasone and aprepitant
What is Dexamethasone and aprepitant?
Dexamethasone and aprepitant is a Small molecule drug developed by Yeditepe University Hospital.
Who makes Dexamethasone and aprepitant?
Dexamethasone and aprepitant is developed and marketed by Yeditepe University Hospital (see full Yeditepe University Hospital pipeline at /company/yeditepe-university-hospital).
What development phase is Dexamethasone and aprepitant in?
Dexamethasone and aprepitant is FDA-approved (marketed).
Related
- Manufacturer: Yeditepe University Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing